Prediction of toxicities of prostate cancer radiotherapy

We treated a cohort of 116 patients with prostate cancer with three-dimensional conformal hypofractionated radiotherapy to a total dose of 52.8 Gy in 16 fractions (3.3 Gy per fraction). The correlation between acute and late gastrointestinal (GI) and genitourinary (GU) toxicity and dose-volume parameters was analysed.

Comparison of observed incidence of toxicity and normal tissue complication probability calculated from dose-volume histograms (DVH) of all patients using radiobiological Lyman-Kutcher-Burman model was performed. The results of our study suggest that acute gastrointestinal toxicity ≥ grade 2 (G2) is the significant predictor of late toxicity ≥ G2 (p=0. 006). Observed incidence of acute and late GI toxicities ≥ G2 was 9. 7% and 11. 5%, respectively. NTCPs of acute and late GI complications ≥ G2 were 11. 3% and 2. 5%. Observed incidence of late GU toxicity ≥ G2 was 14. 2%, NTCP was 0. 8%. Comparison of calculated probability of acute GI toxicity ≥ G2 and observed incidence indicates that parameters of radiobiological models are set appropriately. Comparison of observed incidence of late GI and GU complications ≥ G2 and calculated NTCPs shows the need of refinement of LKB model parameters for acute and late GI and GU complications ≥ G2.   Keywords: prostate cancer, radiotherapy, acute and late toxicity, radiobiological modeling.

Neoplasma. 2015 Dec 07 [Epub ahead of print]

B Hostova, P Matula, P Dubinsky



Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.